ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 157 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2015. The put-call ratio across all filers is 0.97 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $4,789 | -62.1% | 67,735 | -29.4% | 0.00% | – |
Q3 2023 | $12,639 | -74.1% | 95,897 | -11.5% | 0.00% | – |
Q2 2023 | $48,775 | -30.6% | 108,312 | -2.9% | 0.00% | -100.0% |
Q1 2023 | $70,292 | +25.4% | 111,574 | -0.9% | 0.00% | -66.7% |
Q4 2022 | $56,073 | -72.8% | 112,574 | -5.7% | 0.00% | +50.0% |
Q3 2022 | $206,000 | +26.4% | 119,374 | -9.7% | 0.00% | +100.0% |
Q2 2022 | $163,000 | +3.2% | 132,130 | -45.4% | 0.00% | 0.0% |
Q1 2022 | $158,000 | -37.8% | 242,154 | +3.7% | 0.00% | -50.0% |
Q4 2021 | $254,000 | -59.7% | 233,504 | -32.7% | 0.00% | -50.0% |
Q3 2021 | $631,000 | +6.8% | 347,167 | +55.0% | 0.00% | -20.0% |
Q2 2021 | $591,000 | -40.9% | 223,924 | -19.3% | 0.01% | -50.0% |
Q1 2021 | $1,000,000 | +50.4% | 277,609 | +5.1% | 0.01% | +42.9% |
Q4 2020 | $665,000 | +15.5% | 264,214 | +30.5% | 0.01% | 0.0% |
Q3 2020 | $576,000 | -10.1% | 202,441 | +3.6% | 0.01% | -22.2% |
Q2 2020 | $641,000 | +30.8% | 195,441 | -2.3% | 0.01% | 0.0% |
Q1 2020 | $490,000 | -48.0% | 200,141 | +0.2% | 0.01% | -40.0% |
Q4 2019 | $942,000 | +8.9% | 199,707 | +0.7% | 0.02% | +15.4% |
Q3 2019 | $865,000 | +56.1% | 198,357 | +108.6% | 0.01% | +30.0% |
Q2 2019 | $554,000 | +99.3% | 95,086 | +31.7% | 0.01% | +100.0% |
Q1 2019 | $278,000 | +5.3% | 72,192 | -48.8% | 0.01% | -16.7% |
Q4 2018 | $264,000 | -29.0% | 141,132 | +21.5% | 0.01% | -25.0% |
Q3 2018 | $372,000 | +6.0% | 116,166 | +29.9% | 0.01% | -42.9% |
Q1 2018 | $351,000 | +20.2% | 89,440 | +84.2% | 0.01% | +100.0% |
Q3 2017 | $292,000 | +7.7% | 48,567 | +5.7% | 0.01% | 0.0% |
Q2 2017 | $271,000 | +4.2% | 45,949 | +10.6% | 0.01% | 0.0% |
Q1 2017 | $260,000 | +42.9% | 41,541 | +23.4% | 0.01% | +16.7% |
Q4 2016 | $182,000 | -38.5% | 33,666 | -35.8% | 0.01% | -50.0% |
Q3 2016 | $296,000 | -33.3% | 52,454 | -29.5% | 0.01% | -33.3% |
Q2 2016 | $444,000 | -11.2% | 74,433 | +10.6% | 0.02% | -25.0% |
Q1 2016 | $500,000 | +56.7% | 67,320 | +75.4% | 0.02% | +60.0% |
Q4 2015 | $319,000 | – | 38,373 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MSD Partners, L.P. | 15,151,516 | $38,182,000 | 7.99% |
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 10,406,850 | $26,225,000 | 4.02% |
MILLER VALUE PARTNERS, LLC | 12,385,586 | $31,211,000 | 1.12% |
CHIRON CAPITAL MANAGEMENT, LLC | 201,470 | $508,000 | 0.41% |
Sargent Investment Group, LLC | 289,025 | $728,000 | 0.26% |
MAGNOLIA CAPITAL ADVISORS LLC | 80,542 | $404,000 | 0.16% |
XTX MARKETS LLC | 11,086 | $28,000 | 0.14% |
Virtus ETF Advisers LLC | 99,108 | $250,000 | 0.13% |
Old West Investment Management, LLC | 210,226 | $529,000 | 0.12% |
EQUITEC PROPRIETARY MARKETS, LLC | 31,300 | $79,000 | 0.06% |